Serum N-acetyl-β-D-gulucosaminidase activity increases in association with insulin resistance in patients with coronary artery disease

Atherosclerosis

Volumn 149, Issue 1, 2000, Pages 117-122

  Inoue, Teruo ^a   Matsunaga, Riichiro ^a   Morooka, Shigenori ^a   Uehara, Yoshio ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Coronary artery disease; Hyperinsulinemia; Insulin resistance; NAG

Indexed keywords

INSULIN; N ACETYL BETA GLUCOSAMINIDASE;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL;

ACETYLGLUCOSAMINIDASE; AGED; ANALYSIS OF VARIANCE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0033993616     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00293-2     Document Type: Article

References (32)

1. Welman E., Selwin A.P., Peters T.J., Colbeck J.F., Fox K.M. Plasma lysosomal enzyme activity in acute myocardial infarction. Cardiovasc. Res. 12:1978;99-105.
2. Welwood J.M., Ellis B.G., Price R.G., Hammond K., Thompson A.F., Jones N.F. Urinary N-acetyl-β-D-glucosaminidase activities in patients with renal disease. Br. Med. J. 3:1975;408-411.
3. Wollen J.W., Turner P. N-acetyl-β-D-glucosaminidase and β-glucuronidase in health and disease. Clin. Chem. Acta. 12:1965;671-683.
4. Nomura G., Sasaki S., Sumie M., Tashiro H., Toshima H. Serum N-acetyl-β-D-glucosaminidase activity in a large population: a useful index of cardiovascular impairment. Jpn. Circ. J. 68:1982;68-74.
5. Simon G., Altman S. Increased serum N-acetyl-β-D-glucosaminidase activity in human hypertension. Clin. Exp. Hypertens. 4:1982;355-365.
6. Skrha J., Hodinar A., Kvansnicka J., Stibor V., Sperl M., Stolvba P., Hilgertova J. Early changes of serum N-acetyl-β-glucosaminidase, tissue plasminogen activator and erythrocyte superoxide dismutase in relation to retinopathy in type 1 diabetes mellitus. Clin. Chem. Acta. 229:1994;5-14.
7. Uehara Y., Hirawa N., Kawanabe Y., Numabe A., Nagoshi H., Gomi T., Ikeda T., Goto A., Toyo-oka T., Omata M. Serum N-acetyl-β-D-glucosaminidase activity in a genetic rat model of non-insulin dependent diabetes mellitus. Hypertens. Res. 20:1997;193-199.
8. Gensini GG. Coronary arteriography. In: Brawnwald E, editor. Heart Disease. Philadelphia: WB Saunders, 1984. p. 343.
9. Hoffman W.S. A rapid photoelectric method for the determination of glucose in blood and urine. J. Biol. Chem. 120:1937;52-55.
10. Hale C.N., Randle P.J. Immunoassay of insulin with insulin-antibody precipitate. Biochem. J. 88:1963;137-146.
11. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp and its application to the enzymatic assay of total cholesterol in serum. Clin. Chem. 19:1973;1350-1356.
12. Fletcher M.J. Acolorimetric method of estimating serum triglycerides. Clin. Chem. Acta. 22:1968;393-397.
13. Didez L.I. Separation and quantitation of subclasses of human plasma high density lipoproteins by a single precipitation procedure. J. Lipid. Res. 23:1982;1206-1223.
14. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin. Chem. 18:1972;499-502.
15. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostatic model assessment: insulin resistance and β-cell function from fasting glucose and insulin concentration in man. Diabetologia. 28:1985;412-419.
16. Bray G.A. Definitions, measurements and classification of the syndrome of obesity. Int. J. Obes. 2:1978;99-112.
17. Noto A., Ogawa Y., Mori S., Yoshioka M., Kitakaze T., Hori T., Nakamura M., Miyake T. Simple rapid spectrophotometry of urinary N-acetyl-β-D-glucosaminidase, with the use of a new chromogenic substrate. Clin. Chem. 29:1983;1713-1716.
18. Hashimoto R., Adachi H., Nishida H., Tsuruta M., Nomura G. Serum N-acetyl-β-D-glucosaminidase activity in predicting the development of hypertension. Hypertension. 25:1995;1311-1314.
19. Belfiore F., Napoli E., Vecchio L.L., Rabuazzo A. Increased serum N-acetyl-beta-glucosaminidase activity in atherosclerosis. Am. J. Med. Sci. 268:1974;235-239.
20. Linker A., Meyer K., Weissmann B. Enzymatic formation of monosaccharides from hyaluronate. J. Biol. Chem. 213:1955;237-248.
21. Muir H. The structure and metabolism of mucopolysaccharides (glycosaminoglycans) and the problem of the mucopolysaccharides. Am. J. Med. 47:1969;673-690.
22. Silbert J.E. Biochemistry and metabolism of the mucopolysaccharides. Bull. Rheum. Dis. 22:1971;680-685.
23. Kaplan D., Meyer K. The fate of injected mucopolysaccharides. J. Clin. Invest. 41:1962;743-749.
24. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
25. Defronzo R.A., Ferranini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:1991;173-194.
26. Defronzo R.A., Cooke C.R., Andres R., Faloona G.R., Davis P.J. The effect of insulin on renal handling of sodium, potassium, calcium and phosphate in man. J. Clin. Invest. 55:1975;845-855.
27. Moore R.D. Stimulation of Na: H exchange by insulin. Biophys. J. 33:1981;203-210.
28. Rowe J.W., Young J.B., Minaker K.L., Stevens A.L., Pallota J., Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:1981;219-225.
29. Tobey T.A., Greenfield M., Kraemer F., Reaven G.M. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism. 30:1981;165-171.
30. Salamon E.A., Luo J., Murphy L.J. The effect of acute and chronic insulin administration on insulin-like growth factor-1 expression in the pituitary-intact and hypophysectomised rat. Diabetologia. 32:1989;348-353.
31. Yuan X.M., Li W., Olsson A.G., Brunk U.T. The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage. Atherosclerosis. 133:1997;153-161.
32. Li W., Yuan X.M., Olsson A.G., Brunk U.T. Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler. Thromb. Vasc. Biol. 18:1998;177-184.